Betahistine Pellets

(Product under development)
Betahistine PelletsBetahistine hydrochloride (brand names Serc, Betaserc) is an antivertigo drug.

It was first registered in Europe in 1970 for the treatment of Ménière's disease.

It is commonly prescribed to patients with balance disorders or to alleviate vertigo symptoms associated with Ménière's disease.

Available Form:
Betahistine Pellets
Betahistine Granules

Umang Pharmatech equipments used for production of Betahistine Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Betahistine Pellets
Systematic (IUPAC) Name
Betahistine Pellets
Betahistine Pellets
Chemical data
CAS number : 5638-76-6
ATC code : N07CA01
PubChem : CID 2366
DrugBank : DB06698
ChemSpider : 2276
UNII : X32KK4201D
KEGG : D07522
Formula : C8H12N2
Mol. mass : 136.194 g/mol

* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech